循环内皮微粒相关microRNA在巨噬细胞炎性反应诱发小鼠动脉粥样硬化发生的机制

doi:10.3969/j.issn.1674-5817.2019.03.005

摘要/Abstract

摘要： 目的研究循环内皮微粒(EMPs)相关microRNA在巨噬细胞炎性反应诱发动脉粥样硬化(AS)发生的作用机制。方法 SPF级雄性ApoE^-/-小鼠206只,对照组50只,实验组随机分为动脉粥样硬化模型(AS模型)组、NC-miRNA 组和miRNA-19b抑制剂组,每组52只。采用油红染色对AS病变小鼠的组织学进行观察,计算斑块面积相对比例;检测生化指标的表达水平,主要包括小鼠血清高密度脂蛋白胆固醇(HDL-C)、胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)和甘油三酯(TG); ELISA检测血管炎症因子肿瘤坏死因子(TNF-〈)、白细胞介素1(IL-1)、IL-6和IL-10的变化; Western blot检测凋亡相关蛋白B细胞淋巴瘤因子(Bcl-2)、细胞凋亡的标志蛋白PARP降解产物(cleaved-PARP)和B细胞淋巴瘤因子相关X蛋白(Bax)表达的变化, 实时荧光定量PCR检测miR-19b表达; 流式细胞法检测巨噬细胞的凋亡率。结果 miRNA-19b抑制剂组可减少由于AS引起的血管厚度增加,减少AS斑块面积比例; 使血脂中的TC、TG和LDL-C水平降低,HDL-C 水平则有升高; Bax、cleaved-PARP促相关的凋亡蛋白表达量下调,同时Bcl-2抗凋亡蛋白表达上调;血管中促炎症因子IL-1、IL-6和TNF-〈水平降低,抗炎症因子IL-10的水平则升高;同时使血管内巨噬细胞的凋亡率下降。结论 EMPs相关miRNA-19b的存在可以减少巨噬细胞的凋亡,并且通过上调促炎因子促进组织周围炎症的发生,进而促进AS的发展进程。

关键词: 内皮微粒(EMPs), miRNA-19b, 巨噬细胞, 炎症因子, 动脉粥样硬化(AS)

Abstract: Objective To study the mechanism of microRNA related to circulating endothelial particulates (EMPs) on atherosclerosis (AS) induced by inflammatory response of macrophages. Methods There were 206 male ApoE^-/- mice of SPF grade and 50 control groups. The experimental group was randomly divided into three groups: AS model (AS) group, NC-miRNA group and miRNA-19b inhibitor group with 52 in each group, using oil red staining of atherosclerotic lesions in the histology were observed, calculated plaque area ratio, and detect the serum cholesterol (TC), triglyceride (TG), high-density lipoprotein cholesterol (HDL-C) and low density lipoprotein cholesterol (LDL-C) biochemical index expression level of TNF alpha ELISA to detect vascular inflammation factors, IL-1, the change of IL-6 and IL-10, bcl-2, cleaved-PARP and Bax expression were detected by Western blot, mir-19b expression was detected by real-time quantitative PCR, and the apoptosis rate of macrophages was detected by flow cytometry. Results Micrornas-19b inhibitor group can decrease due to the increase in the thickness of the blood vessels of AS, reduce atherosclerotic plaque area percentage, the blood lipid level of TC, TG and LDL-C in the lower, HDL-C level has increased, promoting apoptosis related proteins Bax, cleaved - PARP expression decreased, and resistance to apoptosis related proteins increased the expression of Bcl-2 and proinflammatory factor in vascular IL-1, IL-6 and TNF-〈 level will be significantly lower, anti-inflammatory factor of IL-10 level is higher, At the same time, the apoptosis rate of endovascular macrophages decreased. Conclusion The presence of circulating endothelial microcore-related mirna-19b can reduce the apoptosis of macrophages, and promote the development of peripheral inflammation by up-regulating pro-inflammatory factors, thus promoting the development of AS.

Key words: Cyclic endothelial particles(EMPs), Micrornas-19b, Macrophages, Inflammat-ory factors, Atherosclerosisi (AS)

中图分类号:

R562.2+1Q95-33

孙理华, 张颖, 曹桂秋, 李鹏, 胡强, 张雅玲, 幸世峰. 循环内皮微粒相关microRNA在巨噬细胞炎性反应诱发小鼠动脉粥样硬化发生的机制[J]. 实验动物与比较医学, 2019, 39(3): 201-207.

SUN Li-hua, ZHANG Ying, CAO Gui-qiu, LI Peng, HU Qiang, ZHANG Ya-ling, XING Shi-feng. Mechanism of Circulating Endothelial MicroRNA Related to Atherosclerosis Induced by Inflammatory Response of Macrophages in Mouse[J]. Laboratory Animal and Comparative Medicine, 2019, 39(3): 201-207.

参考文献

[1] Chrysohoou C, Kollia N, Tousoulis D.The link between depression and atherosclerosis through the pathways of inflammation and endothelium dysfunction[J]. Maturitas, 2018, 109(5):1-5.
[2] Jung YY, Kim KC, Park MH, et al.Atherosclerosis is exacerbated by chitinase-3-like-1 in amyloid precursor protein transgenic mice[J]. Theranostics, 2018, 8(3):749-766.
[3] Katakami N.Mechanism of development of atherosclerosis and cardiovascular disease in diabetes mellitus[J]. J Atheroscler Thromb, 2018, 25(1):27-39.
[4] Bornfeldt KE, Kramer F, Batorsky A, et al.A novel type 2 diabetes mouse model of combined diabetic Kidney disease and atherosclerosis[J]. Am J Pathol, 2018, 188(2):343-346.
[5] He PP, Jiang T, Ouyang XP, et al.Lipoprotein lipase: Biosynthesis, regulatory factors, and its role in atherosclerosis and other diseases[J]. Clin Chim Acta, 2018, 480:126-137.
[6] Clément C, Vafadarnejad E, Arampatzi P, et al.Single-cell RNA-Seq reveals the transcriptional landscape and heterogeneity of aortic macrophages in murine atherosclerosis[J]. Clin Chim Acta, 2018, 125(12):126-137.
[7] Richardson G, Sage A, Bennaceur K, et al.Telomerase mediates lymphocyte proliferation but not the atherosclerosis-suppressive potential of regulatory T-cells[J]. Arterioscler Thromb Vasc Biol, 2018, 38(6):1283-1296.
[8] Zhong X, Ma X, Zhang L, et al.MIAT promotes proliferation and hinders apoptosis by modulating miR-181b/STAT3 axis in ox-LDL-induced atherosclerosis cell models[J]. Biomed Pharmacother, 2018, 97(1):1078-1082.
[9] Zernecke A, Haring B, Selvin E, Liang M, et al.Dietary protein sources and risk for incident chronic kidney disease: results from the atherosclerosis risk in communities (ARIC) study[J]. J Ren Nutr, 2018, 27(4):233-242.
[10] Kim H J, Cha G S, Kim H J, et al.Porphyromonas gingivalis accelerates atherosclerosis through oxidation of high-density lipoprotein[J]. J Periodontal Implant Sci, 2018, 48(1):60-68.
[11] Li C, Li S, Zhang F, et al.Endothelial microparticles-mediated transfer of microRNA-19b promotes atherosclerosis via activating perivascular adipose tissue inflammation in apoE-/- mice[J]. Biochem Biophys Res Commun, 2018, 495(2):1922-1929.
[12] Huang Y, Qi Y, Du J Q, et al.Protosappanin A protects against atherosclerosis via anti- hyperlipidemia, anti-inflammation and NF-κB signaling pathway in hyperlipidemic rabbits:[J]. Iran J Basic Med Sci, 2018, 21(1): 33-38.
[13] Qamar T, Norby F L, Aguilar D, et al.Galectin-3 and incidence of atrial fibrillation: The atherosclerosis risk in communities (ARIC) study[J]. Am Heart J, 2018, 192(11):19-25.
[14] Souilhol C, Goodspeed L, Wang S, et al. Deficiency of invariant natural killer T cells does not protect against obesity but exacerbates atherosclerosis in Ldlr-/- mice[J]. Int J Mol Sci, 2018, 19(2):pii:E510.
[15] Feng M, Xu D, Wang L. miR-26a inhibits atherosclerosis progression by targeting TRPC3[J]. Cell Biosci, 2018, 8:4.
[16] Naugler C, Harmsen MC, Evans PC, et al.Endothelial-mesenchymal transition in atherosclerosis[J]. Cardiovasc Res, 2018: 114(4):565-577.
[17] Tabib A, Leroux C, Mornex J F, et al.Accelerated coronary atherosclerosis and arteriosclerosis in young human-immunodeficiency-virus-positive patients[J]. Coron Artery Dis, 2018, 11(1):41-45.
[18] Canakinumab A, Macfadyen JG, Thuren T, et al.Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial[J]. Lancet, 2017, 390(10105):1833-1837.
[19] Yuan N, Zhang HF, Wei Q, et al.Expression of CD4+CD25+Foxp3+ Regulatory T cells, interleukin 10 and transforming growth factor β in newly diagnosed type 2 diabetic patients[J]. Exp Clin Endocrinol Diabetes, 2018, 126(2):96-101.
[20] Souihol C, Harmsen MC, Evans PC, et al.Endothelial-mesenchymal transition in atherosclerosis[J]. Cardiovasc Res, 2018, 114(4):565-577.
[21] Ling QQ, Zhao J, Zheng CG, et al.Roles of notch signaling pathway and endothelial-mesenchymal transition in vascular endothelial dysfunction and atherosclerosis[J]. Eur Rev Med Pharmacol Sci, 2018, 22(19):6485-6491.
[22] Sun L, Dou F, Chen J, et al.Salidroside slows the progression of EA.hy926 cell senescence by regulating the cell cycle in an atherosclerosis model[J]. Mol Med Rep, 2018, 17(1):257-263.